Drug class in one race

TNF-alpha drugs for Ulcerative Colitis

22 tracked TNF-alpha drugs in the Ulcerative Colitis race. The class explanation lives on the TNF-alpha page; the full indication pipeline across every mechanism is on the Ulcerative Colitis page.

19 approved / phase 41 Phase 31 Phase 21 Phase 1

Head-to-head evidence: CT-P13 vs Hemay007 · CT-P13 vs SOR102 · adalimumab vs CT-P13 · CT-P13 vs golimumab · CT-P13 vs infliximab · CT-P13 vs infliximab-dyyb (Zymfentra)

The roster

← all TNF-alpha drugs